RBC Capital raises target for CSL stock to AUD 213.00
Published on 10/08/2026 at 09:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRBC Capital upgraded CSL to Buy and raised its price target from AUD 148.00 to AUD 213.00 on October 8, 2026, according to IBTimes Australia. The AUD 65.00 increase equals 43.92 percent, giving the analyst action a clear valuation signal even as the euro quote was lower on the morning snapshot.
Target reset meets difficult results
CSL reported US$15.80 billion revenue for fiscal 2026, a 1.00 percent decline on a constant-currency basis, according to Simply Wall St. The company also reported a statutory net loss of US$2.60 billion, largely reflecting US$7.10 billion in pre-tax impairment and restructuring charges.
Underlying NPAT, CSL's preferred adjusted profit measure, was US$3.10 billion in fiscal 2026, down 2.00 percent, the same source reported. That mix explains why the higher target depends on a recovery in operating performance rather than on the latest statutory result alone.
Market value and earnings date
CSL's market capitalization was AUD 86.9 billion on October 8, 2026, while its 52-week range was AUD 90.00 to AUD 222.47. The current market value sits AUD 41.01 below the yearly high, a 18.43 percent distance calculated from the same-currency range.
CSL lists its annual general meeting for October 27, 2026. Simply Wall St identifies February 10, 2027 as the next earnings date, placing the next major reported checkpoint after the AGM.
CSL stock remains below its high
CSL stock was trading at EUR 112.44 at Lang & Schwarz on October 8, 2026 at 9:00 a.m. CEST, down 0.13 percent versus the prior close of EUR 112.59 at Lang & Schwarz on October 7, 2026. The neutral daily move leaves the RBC target revision and the path back toward positive earnings growth as the main valuation reference.
The further course of trading is shown by the continuously updated real-time quote of CSL stock.
CSL market data
- Company: CSL Limited
- ISIN: AU000000CSL8
- Ticker: CSL.AX
- Primary exchange: ASX
- Price Lang & Schwarz (as of October 8, 2026, 9:00 a.m. CEST): EUR 112.44
- Change versus prior close: minus 0.13 percent
- Prior close Lang & Schwarz (October 7, 2026): EUR 112.59
- Market capitalization: AUD 86.9 billion (as of October 8, 2026)
- 52-week range: AUD 90.00-222.47 (as of October 8, 2026)
- Sector / Industry: Healthcare / Biotechnology
- Index membership: S&P/ASX 200
- Next earnings date: February 10, 2027
